​

Aprea Therapeutics Ownership | Who Owns Aprea Therapeutics?

OverviewForecastRevenueFinancialsChart

Aprea Therapeutics Ownership Summary

Aprea Therapeutics is owned by 29.84% institutional investors, 11.30% insiders, and 58.86% retail investors. Aigh capital management is the largest institutional shareholder, holding 8.87% of APRE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.67% of its assets in Aprea Therapeutics shares.

APRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAprea Therapeutics29.84%11.30%58.86%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigh capital management539.30K8.87%$912.99K
Sio capital management279.37K4.59%$472.13K
Sphera funds management270.00K4.44%$456.30K
Nantahala capital management205.76K3.38%$347.73K
Dafna capital management137.17K2.25%$231.82K
Blackrock funding, inc. /de8.50K0.14%$14.37K
Stonepine capital management---
Exome asset management---
Princeton global asset management---
Nbc securities---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management539.30K0.41%$912.99K
Sio capital management279.37K0.18%$472.13K
Sphera funds management270.00K0.11%$456.30K
Dafna capital management137.17K0.06%$231.82K
Nantahala capital management205.76K0.01%$347.73K
Nbc securities---
Blackrock funding, inc. /de8.50K-$14.37K
Exome asset management---
Princeton global asset management---
Stonepine capital management---

Top Buyers

HolderShares% AssetsChange
Sio capital management279.37K0.18%2.77K
Nantahala capital management205.76K0.01%-
Dafna capital management137.17K0.06%-
Aigh capital management539.30K0.41%-
Sphera funds management270.00K0.11%-

Top Sellers

HolderShares% AssetsChange
Stonepine capital management---102.24K
Exome asset management---28.97K
Nbc securities---899.00
Princeton global asset management---100.00
Jpmorgan chase---10.00

Sold Out

HolderChange
Jpmorgan chase-10.00
Princeton global asset management-100.00
Nbc securities-899.00
Exome asset management-28.97K
Stonepine capital management-102.24K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202523-11.54%1,815,208-6.90%292.82%740.00%4-42.86%
Mar 31, 202526-1,949,704-6.15%322.29%5-50.00%775.00%
Dec 31, 20242618.18%2,077,3813.81%373.32%1066.67%433.33%
Sep 30, 20241-899--3302.80%----
Jun 30, 20241-50.00%899-10.01%-2809.42%--100.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF145.28K2.67%-
Vanguard Total Stock Mkt Idx Inv142.17K2.57%-3.11K
Fidelity Extended Market Index24.41K0.44%-
Vanguard Institutional Extnd Mkt Idx Tr19.62K0.35%-8.94K
DFA US Targeted Value I7.98K0.14%-
Fidelity Total Market Index7.20K0.13%-
Fidelity Series Total Market Index5.85K0.11%-
Dimensional US Targeted Value ETF3.52K0.06%-
Spartan Extended Market Index Pool F3.18K0.06%-
Spartan Extended Market Index Pool E2.95K0.05%212.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 03, 2025Gilad Oren President/CEOBuy$5.62K
Apr 03, 2025Gilad Oren President/CEOBuy$4.49K
Oct 18, 2024Duey Marc-Sell$29.58K
Oct 23, 2024Gilad Oren President/CEOBuy$1.96K
Oct 16, 2024Duey Marc-Buy$131.70K

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q491
2024 Q2--
2024 Q112-

APRE Ownership FAQ

Who Owns Aprea Therapeutics?

Aprea Therapeutics shareholders are primarily institutional investors at 29.84%, followed by 11.30% insiders and 58.86% retail investors. The average institutional ownership in Aprea Therapeutics's industry, Biotech Stocks , is 304.14%, which Aprea Therapeutics falls below.

Who owns the most shares of Aprea Therapeutics?

Aprea Therapeutics’s largest shareholders are Aigh capital management (539.3K shares, 8.87%), Sio capital management (279.37K shares, 4.59%), and Sphera funds management (270K shares, 4.44%). Together, they hold 17.90% of Aprea Therapeutics’s total shares outstanding.

Does Blackrock own Aprea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aprea Therapeutics.

Who is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.41% of its assets in 539.3K Aprea Therapeutics shares, valued at 912.99K$.

Who is the top mutual fund holder of Aprea Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aprea Therapeutics shares, with 2.67% of its total shares outstanding invested in 145.28K Aprea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools